Joslin Diabetes Center Partners With Phytel on CME Research Project

DALLAS, TX and BOSTON, MA, Apr 12 (Marketwire) --
Phytel, the leader in physician-led population health improvement, and
the Joslin Diabetes Center, a Harvard Medical School affiliate in the
forefront of the fight against diabetes, today announced their
collaboration on a landmark research initiative to compare the accuracy
and predictive value of current assessment methodologies for continuing
medical education (CME) programs. The results will be used to inform
ongoing efforts to improve diabetes care.

The study will compare four methods of evaluating educational outcomes in
diabetes care: physician self-reports, competency assessments based on
case studies, examination of a sample of patient charts, and data drawn
from Phytel clients' electronic registries, which cover all of a
practice's patients with diabetes.

Joslin chose Phytel as its partner in this study because of Phytel's
large customer base and its ability to provide population-wide data.
Hundreds of physician groups and healthcare systems that collectively
care for over 20 million patients use Phytel's patient outreach, care
management, patient engagement, transitions of care, and analytics
solutions in population health management.

Joslin and Phytel expect the study to commence in April or May and to be
completed by the end of the year.

"Joslin's grant requires our researchers to explore the most effective
methods of verifying outcomes of educational interventions to further the
adoption of best practices in diabetes care," noted Julie Brown, CCMEP,
director of professional education, Joslin Diabetes Center. "Phytel's
expertise in population health management and its comprehensive database
will enable Joslin to make valid comparisons among different methods of
assessing performance and patient level outcomes relative to educational
and non-educational interventions."

Steve Schelhammer, CEO of Phytel, commented, "We are honored to be part
of this important study by the Joslin Diabetes Center. The research will
help improve medical education and will supply a firmer basis for
evaluating care team performance. Phytel customers that participate in
this research will benefit in part through their front line involvement
in an innovative effort for measuring improvement in diabetes care."

"Today's CME is much more about quality and continuous quality
improvement than it is about lectures and tests," continued Brown. "And
Joslin's program is completely performance focused. We view CME as a tool
for everyday practice, not just something you need to 'go get.' This
innovative research in CME -- funded through independent medical
education grants provided by GlaxoSmithKline, Pfizer, Inc., and Lilly &
Co. -- we hope will be groundbreaking relative to accurately assessing
outcomes in a scalable, efficient manner that is beneficial to all
stakeholders."

About Phytel
The premier company empowering physician-led population
health improvement, Phytel provides physicians with proven technology to
deliver timely, coordinated care to their patients. Phytel's
state-of-the-art registry, which now encompasses 20 million patients
nationwide, uses evidence-based chronic and preventive care protocols to
identify and notify patients due for service, while tracking compliance
and measuring quality and financial results. For more information, please
visit www.phytel.com. Follow us on Twitter and find us on Facebook.

About Joslin Diabetes Center
Joslin Diabetes Center, located in Boston,
Massachusetts, is the world's largest diabetes research and clinical care
organization. Joslin is dedicated to ensuring that people with diabetes
live long, healthy lives and offers real hope and progress toward
diabetes prevention and a cure. Joslin is an independent, nonprofit
institution affiliated with Harvard Medical School. The Joslin Diabetes
Center Professional Education Department has been nationally accredited
since 1995 and was awarded Accreditation with Commendation in 2006 by the
ACCME, the highest level available. The department is focused on
performance improvement and supports quality diabetes practice for over
40,000 primary care practitioners annually. Please join us this fall in
Washington DC at Joslin's first ever major national convening event,
Diabetes Innovation 2012. (www.diabetesinnovation.org). For more
information, please visit www.joslin.org.

Contact:
Brenda Bryan
Amendola Communications
480-664-8412 Ext. 13
bbryan@acmarketingpr.com

Copyright 2012, Marketwire, All rights reserved.

-0-